At Bayer, we are helping to drive medical progress through our focus on researching, developing, and marketing innovative medicines. Our near-term growth is driven by key products in cardiovascular therapy area, while our near- and mid-term growth will be further fueled by launch products in oncology, cardiovascular and cardiorenal areas and late-stage R&D pipeline candidates in cardiovascular therapy area. To safeguard long-term growth, we continue to invest in R&D in therapeutic areas with a substantial need for innovation. Moreover, we are expanding our efforts to access external innovation through research collaborations and in-licensing, capturing continued growth opportunities in biologics and novel technologies. Another key focus is on improving women’s health and strengthening their role in society by helping to promote gender equality and women’s economic participation. As part of this endeavor, we are leveraging our leading position in women’s health and are aiming to provide 100 million women in low- and middle-income countries with access to modern contraception by 2030. In addition, we remain committed to combating neglected tropical diseases and noncommunicable diseases.
-
VuorotyönjohtajiaPharma · Bayer Finland, Turku
-
Scientific DirectorPharma · Bayer Norway · Hybrid
-
Validation and Qualification Engineer - Lab Infrastructure ResponsiblePharma · Bayer Norway
About Bayer Nordic
At Bayer we always start by listening – because our customers are at the heart of everything we do. The needs of our customers and the challenges facing society inspire us to develop ideas that improve people’s lives. As part of the Bayer team, each of us needs to thoroughly understand and support our customers in order to deliver products and solutions that matter – now and in the future
Bayer Nordic is our regional organization for Northern Europe. You find us in Finland, Denmark, Norway, Sweden, Iceland and the Baltic countries, i.e. Estonia, Latvia and Lithuania. We are more than 1400 people who are passionate to make a difference.
In the Nordic region we have two global R&D and production sites, in Finland and Norway. The Turku-based production facility is one of the Group's global pharmaceutical production facilities, where medicines are manufactured for more than 130 countries. Over the last years Bayer has increased its investments, research activities and partnerships in the Nordics, and we are proud of being one of the most significant Life Science companies in the region.
Why Bayer? Because we’re a pioneer in the fields of human and plant health. Because we invent the solutions that will create a sustainable future for our planet. Because a career with Bayer means you can put your passion into practice and make an impact.